"Dead money stock"???.....Price-stable during dire economy times + great dividens + historically speaking, possible split now that the stock is again keeping its head above 70...
In light of recent news regarding Guidant's serious problems, I do not believe we, JNJ stockholders, should give too much credit to Weldon's management team for not having adquired a "sick" Guidant. The fact is that we were saved of this mess by the incredible stupidity of BSX and not by JNJ having done a good, professional DD job. We better pray that Weldon's team has learned a lesson and does better in the future.
Other than JNJ's strong fundamentals and one-time recent positive developments (proposed adquisition of Guidant, initial legal victory over BSX), what else is going on that would support such a stron showing today?
Disclosure: Long on JNJ (since Alza merger)
Sorry to hear about your "pearls of sorrow" but it gives me some comfort that when I say OUCHHHHH the echo reverberates with other BSX sufferers, ha, ha, ha.
Long but I don'tnow until when
24+ millions shares traded today. If the "bad news" have been known selectively, why the rush to trade today?
Disclosure: Modest long position and still holding my breath!
Please, please stop wasting time on the subject since we can not do anything about it. Instead, let us concentrate on important subjects that may affect JNJ on a positive or negative way. I apologize if I offend someone's sensibilities with this request but I had to get it off my chest.
Long since Alza was purchased by JNJ
Point well-made! However, if you wish to talk about whom to believe: 1) Do you really know your broker and his own agenda? 2) Do you really know the analysts whose stocks reviews you consider before buying a stock? etc, etc.
I've been reading Bookemdano9's for awhile and he "seems" and "sounds" as knowledgeable and insightful on BSX as any of my brokers. Did I make a mistake in taking a position on BSX primarily based on his opinions? Probably YES!!!!, but based on the above, and with all due respect, your analogy about taking candy from a stranger is too simplistic.
Thank you for your "explanations". I really don't believe that your losing 100K is going to mollify some of us who bought BSX on your analysis of last week but, if true, it shows that even a well-informed investor like yourself can get hurt also. For the time being, I am still holding my long position.
I bought heavy last Friday on your "recommendations" and now I cannot hear a valid explanation from you as to the reason(s) for today's debacle. What's holding you up?.......You better come on board soon or I'll sick lagrammy on you on a heart-beat.
Your silence is so loud I can hear you as my BSX ship is going down in flames....How do you explain today's ass-whipping of all the "positive" b.s. on BSX you have posted on this board?.....
........."The Company also said that since it modified its manufacturing process, implemented new tracking software and introduced new inspection protocols, it has not yet had any confirmed no-deflate complaints caused by focal neckdown in non-recalled units, although some complaints remain under investigation. Since July 16, the Company has shipped more than 100,000 new TAXUS units."..............
It has not yet had any confirmed complaints? This sound like management trying to "sugar-coat" the fact that the "old problems" are still prevalent in the new units shipped after July 16. IMHO
Thank you for your response. I am still generally concerned about the reaction of Cordis/JNJ management to the FDA 483. I agree with you that a few short months since April is not sufficient a sufficient time-period to "correct" the problems but it appears that Cordis/JNJ management has neither corrected nor addressed the problems in a manner satisfactory to the FDA. I am also concerned that if in fact the problems are not technical but of a QSM nature, why in the world does not JNJ deal with them in a straight forward manner, let its actions be known not only to the FDA but to the general public and in doing so protect the value of its stock.
I am still bullish on JNJ but recent actions (or lack of them) by present management are creating some doubts in my investor's mind.